Basudeb Maji

Title: The Innovative Contributions of Basudeb Maji

Introduction

Basudeb Maji is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of advanced methods for gene editing and control.

Latest Patents

Maji holds 4 patents, with his latest innovations focusing on groundbreaking techniques in CRISPR technology. One of his notable patents is titled "Methods and compositions for optochemical control of CRISPR-CAS9." This patent discloses non-naturally occurring or engineered DNA- or RNA-guided nuclease systems, which include CRISPR enzymes associated with destabilization domains and photocaged stabilization ligands. These innovations involve compositions, systems, and complexes that enhance the delivery and efficacy of nucleic acid editing systems. Another significant patent is "Inhibitors of RNA-guided nuclease target binding and uses thereof." This patent details compositions and methods for inhibiting the activity of RNA-guided endonucleases, along with methods for identifying such compositions. It also covers treatment methods using these inhibitory compounds.

Career Highlights

Throughout his career, Basudeb Maji has worked with esteemed organizations such as the Broad Institute, Inc. and Brigham and Women's Hospital, Inc. His work has been pivotal in advancing the understanding and application of CRISPR technology in various biomedical fields.

Collaborations

Maji has collaborated with notable colleagues, including Amit Choudhary and Debasish Manna. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Basudeb Maji's contributions to biotechnology and gene editing are noteworthy, as evidenced by his patents and collaborations. His work continues to influence the field and pave the way for future innovations in genetic research.